Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML

DNA and Cell Biology

Volumn 31, Issue 11, 2012, Pages 1628-1635

  Zha, Xianfeng ^a   Chen, Shaohua ^a   Yang, Lijian ^a   Shi, Li ^a   Li, Bo ^a   Wu, Xiuli ^a   Lu, Yuhong ^a   Li, Yangqiu ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD3; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LYMPHOCYTE ACTIVATION; MICROSCOPY, FLUORESCENCE; MUROMONAB-CD3; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFECTION; UP-REGULATION;

EUKARYOTA;

EID: 84868015040     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1798     Document Type: Article

References (35)

1. Call, M.E., Pyrdol, J., and Wucherpfennig, K.W. (2004). Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. EMBO J 23, 2348-2357.
2. Call, M.E., and Wucherpfennig, K.W. (2005). The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 23, 101-125.
3. Chen, S., Huang, X., Chen, S., Yang, L., Shen, Q., Zheng, H., Li, B., Grabarczyk, P., Przybylski, G.K., Schmidt, C.A., and Li, Y. (2012). The role of BCL11B in regulating the proliferation of human naive T cells. Hum Immunol 73, 456-464.
4. Chen, S., Yang, L., Chen, S., and Li, Y. (2009). TCR zeta chain expression in T cells from patients with CML. Hematology 14, 95-100.
5. Chen, S., Zha, X., Yang, L., Li, B., Liye, Z., and Li, Y. (2011). Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients. Hematology 16, 31-36.
6. Chen, X., Woiciechowsky, A., Raffegerst, S., Schendel, D., Kolb, H.J., and Roskrow, M. (2000). Impaired expression of the CD3- zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 111, 817-825.
7. Chowdhury, B., Tsokos, C.G., Krishnan, S., Robertson, J., Fisher, C.U., Warke, R.G., Warke, V.G., Nambiar, M.P., and Tsokos, G.C. (2005). Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3¢-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J Biol Chem 280, 18959-18966.
8. Clay, T.M., Custer, M.C., Sachs, J., Hwu, P., Rosenberg, S.A., and Nishimura, M.I. (1999). Efficient transfer of a tumor antigenreactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 163, 507-513.
9. Clevers, H., Alarcon, B., Wileman, T., and Terhorst, C. (1988). The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 6, 629-662.
10. Engels, B., and Uckert, W. (2007). Redirecting T lymphocyte specificity by T cell receptor gene transfer - a new era for immunotherapy. Mol Aspects Med 28, 115-142.
11. Fischer, A., de Saint Basile, G., and Le Deist, F. (2005). CD3 deficiencies. Curr Opin Allergy Clin Immunol 5, 491-495.
12. Frydecka, I., Bocko, D., Kosmaczewska, A., Ciszak, L., and Morilla, R. (2001). The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease. Br J Cancer 84, 1339-1343.
13. Heemskerk, M.H. (2010). T-cell receptor gene transfer for the treatment of leukemia and other tumors. Haematologica 95, 15-19.
14. Herndon, T.M., Juang, Y.T., Solomou, E.E., Rothwell, S.W., Gourley, M.F., and Tsokos, G.C. (2002). Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 103, 145-153.
15. Jabbour, E., Cortes, J., and Kantarjian, H. (2009). Treatment selection after imatinib resistance in chronic myeloid leukemia. Target Oncol 4, 3-10.
16. Li, Y. (2008). Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Hematology 13, 267-275.
17. Li, Y., Chen, S., Yang, L., Chen, S., Lin, C., Wang, L., Lu, Y., Geng, S., Du, X., and Schmidt, C.A. (2011a). Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. Hematology 16, 143-150.
18. Li, Y., Geng, S., Du, X., Chen, S., Yang, L., Wu, X., Li, B., Schmidt, C.A., and Przybylski, G.K. (2011b). Restricted TRBV repertoire in CD4+ and CD8 + T-cell subsets from CML patients. Hematology 16, 43-49.
19. Li, Y., Geng, S., Yin, Q., Chen, S., Yang, L., Wu, X., Li, B., Du, X., Schmidt, C.A., and Przybylski, G.K. (2010). Decreased level of recent thymic emigrants in CD4+ and CD8 + T cells from CML patients. J Transl Med 8, 47.
20. Mozaffari, F., Hansson, L., Kiaii, S., Ju, X., Rossmann, E.D., Rabbani, H., Mellstedt, H., and Osterborg, A. (2004). Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage. Br J Haematol 124, 315-324.
21. Nambiar, M.P., Enyedy, E.J., Fisher, C.U., Warke, V.G., Juang, Y.T., and Tsokos, G.C. (2001). Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes. Cell Immunol 208, 62-71.
22. Nambiar, M.P., Fisher, C.U., Warke, V.G., Krishnan, S., Mitchell, J.P., Delaney, N., and Tsokos, G.C. (2003). Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 48, 1948-1955.
23. Quintas-Cardama, A., and Cortes, J. (2009). Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113, 1619-1630.
24. Rappl, G., Riet, T., Awerkiew, S., Schmidt, A., Hombach, A.A., Pfister, H., and Abken, H. (2012). The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells. PLoS One 7, e30713.
25. Renner, C., Ohnesorge, S., Held, G., Bauer, S., Jung, W., Pfitzenmeier, J.P., and Pfreundschuh, M. (1996). T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 88, 236-241.
26. Rezvany, M.R., Jeddi-Tehrani, M., Osterborg, A., Kimby, E., Wigzell, H., and Mellstedt, H. (1999). Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 94, 1063-1069.
27. Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., and Saiki, I. (2003). Tumor necrosis factoralpha- induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278, 36916-36923.
28. Savona, M., and Talpaz, M. (2008). Getting to the stem of chronic myeloid leukaemia. Nat Rev Cancer 8, 341-350.
29. Schmitz, M.L., Bacher, S., and Dienz, O. (2003). NF-kappaB activation pathways induced by T cell costimulation. FASEB J 17, 2187-2193.
30. Smahel, M. (2011). Antigens in chronic myeloid leukemia: implications for vaccine development. Cancer Immunol Immunother 60, 1655-1668.
31. Stroncek, D.F., Berger, C., Cheever, M.A., Childs, R.W., Dudley, M.E., Flynn, P., Gattinoni, L., Heath, J.R., Kalos, M., Marincola, F.M., Miller, J.S., Mostoslavsky, G., Powell, D.J., Jr., Rao, M., Restifo, N.P., Rosenberg, S.A., O'Shea, J., and Melief, C.J. (2012). New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med 10, 48.
32. Torelli, G.F., Paolini, R., Tatarelli, C., Soriani, A., Vitale, A., Guarini, A., Santoni, A., and Foa, R. (2003). Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. Br J Haematol 120, 201-208.
33. Xue, S., Gillmore, R., Downs, A., Tsallios, A., Holler, A., Gao, L., Wong, V., Morris, E., and Stauss, H.J. (2005). Exploiting T cell receptor genes for cancer immunotherapy. Clin Exp Immunol 139, 167-172.
34. Yin, Q., Zha, X., Yang, L., Chen, S., Zhou, Y., Wu, X., and Li, Y. (2011). Generation of diffuse large B cell lymphoma-associated antigen-specific Valpha6/Vbeta13 + T cells by TCR gene transfer. J Hematol Oncol 4, 2.
35. Zha, X., Chen, S., Yang, L., Li, B., Chen, Y., Yan, X., and Li, Y. (2011). Characterization of the CDR3 structure of the Vbeta21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia. Hum Immunol 72, 798-804.